SCHEMBL28029905

SCHEMBL28029905

CC(C)(C)C(=O)OCC1(CNCc2ccccc2)CCNC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
ATM Q13315 2/20 0.36
PPID Q08752 1/20 0.35
TACR1 P25103 1/20 0.35
CDK1 P06493 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
CDK7 P50613 1/20 0.35
CCNH P51946 1/20 0.35
MNAT1 P51948 1/20 0.35
OPRM1 P35372 2/20 0.34
LMNA P02545 1/20 0.34
ENO1 P06733 1/20 0.34
KMT2A Q03164 1/20 0.34
OPRL1 P41146 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MITF O75030 1/20 0.33
GAA P10253 1/20 0.33
CYP2D6 P10635 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28114744 0.80 OPRM1 (0.42) TACR1OPRM1LMNACYP2D6SLC6A2
SCHEMBL4522027 0.71 SYK (0.46) ATMKMT2ACYP2D6SLC6A2SLC6A4
SCHEMBL27783464 0.71 PRKCA (0.38) SMN1; SMN2
SCHEMBL27748184 0.70 TACR1 (0.52) TACR1OPRM1SLC6A4
SCHEMBL1224694 0.69 TACR1 (0.41) TACR1KMT2AGAACYP2D6SLC6A2
SCHEMBL1224690 0.69 TACR1 (0.41) TACR1KMT2AGAACYP2D6SLC6A2
SCHEMBL27598326 0.68 CHRNA7 (0.37) KMT2A
SCHEMBL28000343 0.67 SMN1; SMN2 (0.33) SMN1; SMN2OPRM1
SCHEMBL28106576 0.67 PRKCA (0.36)
SCHEMBL6643951 0.67 SLC6A2 (0.42) CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105348266-A Substituted-3-chlorin-N-[3-(pyrimidine-2-ylamine)phenyl]propanamide or salts thereof ASTRAZENECA AB 2016-02-24 CN disclosed
CN-105254616-A 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS and salts thereof ASTRAZENECA AB 2016-01-20 CN disclosed
CN-105198862-A 2 - (2, 4, 5 - SUBSTITUTED -ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER ASTRAZENECA AB 2015-12-30 CN disclosed
CN-105175396-A Substituted 4-methoxy-N3-(pyrimidin-2-yl) benzene-1, 3-diamine compounds and salts thereof ASTRAZENECA AB 2015-12-23 CN disclosed
CN-103702990-B 2- (2,4, 5-substituted aniline) pyrimidine derivatives as EGFR modulators for the treatment of cancer ASTRAZENECA AB (SE) 2015-09-09 CN disclosed